Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.350
+0.090 (7.14%)
Aug 29, 2025, 4:00 PM - Market closed

Kairos Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21
2820---
Enterprise Value
2416---
Last Close Price
1.261.52---
PB Ratio
3.734.09---
P/TBV Ratio
4.644.29---
Debt / Equity Ratio
---0.31-0.50-0.34
Quick Ratio
4.491.280.040.270.04
Current Ratio
7.164.200.040.270.04
Return on Equity (ROE)
-281.84%-192.96%---
Return on Assets (ROA)
-73.85%-43.50%-107.07%-39.41%-
Return on Capital (ROIC)
-137.88%-87.69%---
Earnings Yield
-17.34%-13.33%---
Buyback Yield / Dilution
-35.55%-9.38%-1.42%-11.86%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q